Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0020 (-3.33%)
Aug 28, 2026, 3:27 PM AEST
Control Bionics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -14.53 | -6.11 | -5.91 | -5.63 | -6.1 |
Depreciation & Amortization | 0.79 | 0.99 | 0.84 | 0.48 | 0.51 |
Loss (Gain) From Sale of Assets | 0.02 | 0.01 | - | - | - |
Loss (Gain) on Equity Investments | 0.05 | 0.06 | - | - | - |
Stock-Based Compensation | 0.22 | 0.12 | 0.14 | 0.04 | 0.05 |
Provision & Write-off of Bad Debts | 0.28 | 0.24 | 0.51 | 0.63 | 0.08 |
Other Operating Activities | 7.46 | 0.01 | -0.02 | 0.06 | -0.41 |
Change in Accounts Receivable | - | -0.07 | -0.76 | -0.24 | -0.42 |
Change in Inventory | -0.04 | -0.01 | -0.05 | 0.12 | -0.65 |
Change in Accounts Payable | -0.01 | 0.44 | 0.37 | 0.32 | -0.01 |
Change in Other Net Operating Assets | 0.01 | 0.04 | -0.02 | -0.31 | 0.06 |
Operating Cash Flow | -5.75 | -4.27 | -4.91 | -4.54 | -6.89 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.01 | -0.3 | -0.4 | -0.42 | -0.15 |
Cash Acquisitions | 0.01 | - | - | - | - |
Sale (Purchase) of Intangibles | -0.2 | -0.14 | -0.07 | -0.04 | - |
Investment in Securities | -0.06 | -0.3 | - | - | - |
Investing Cash Flow | -0.27 | -0.74 | -0.47 | -0.46 | -0.15 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 1.06 | 0.23 | 0.65 | - | 0.24 |
Total Debt Issued | 1.06 | 0.23 | 0.65 | - | 0.24 |
Short-Term Debt Repaid | -0.67 | -0.65 | -0.13 | -0.05 | -0.19 |
Long-Term Debt Repaid | -0.24 | -0.16 | -0.05 | -0.11 | -0.09 |
Total Debt Repaid | -0.91 | -0.82 | -0.18 | -0.16 | -0.29 |
Net Debt Issued (Repaid) | 0.15 | -0.59 | 0.47 | -0.16 | -0.05 |
Issuance of Common Stock | 7.56 | 5.41 | 5.09 | 0.86 | 0.01 |
Other Financing Activities | -0.22 | -0.19 | -0.14 | - | -0.06 |
Financing Cash Flow | 7.49 | 4.63 | 5.43 | 0.71 | -0.09 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0.02 | 0 | 0 | 0.01 | 0 |
Net Cash Flow | 1.48 | -0.39 | 0.05 | -4.28 | -7.12 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.76 | -4.57 | -5.31 | -4.96 | -7.03 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -106.63% | -74.40% | -99.24% | -87.84% | -156.26% |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.03 | -0.06 | -0.08 |
Levered Free Cash Flow | -3.18 | -2.45 | -2.59 | -2.56 | -5.37 |
Unlevered Free Cash Flow | -3.13 | -2.38 | -2.56 | -2.54 | -5.37 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 0.05 | 0.06 | 0.02 | 0.04 |
Change in Working Capital | -0.04 | 0.41 | -0.46 | -0.11 | -1.02 |